World's Best Scientists 2026 revealed!
Cornelis J. A. Punt

Cornelis J. A. Punt

D-Index & Metrics

Medicine

D-Index
98
Citations
46106
World Ranking
8790
National Ranking
345

Overview

Cornelis J. A. Punt is affiliated with the University of Amsterdam in the Netherlands and has a significant body of research within the field of Medicine, with a primary focus on Oncology. Their work encompasses a range of subfields including Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery, and Hepatology. Their research concentrates mainly on colorectal cancer, genetic factors influencing colorectal cancer, hepatocellular carcinoma treatment and prognosis, gastric cancer management, cancer genomics and diagnostics, colorectal cancer surgical treatments, and the application of radiomics and machine learning in medical imaging.

They have authored multiple papers published in various notable journals. Some recent publications include:

  • Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer, 2020, New England Journal of Medicine
  • Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial, 2020, Journal of Clinical Oncology
  • Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study, 2022, The Lancet Oncology
  • Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial, 2021, Journal of Clinical Oncology
  • Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial, 2021, The Lancet Oncology

The scientist has collaborated frequently with several co-authors throughout their career, including Miriam Koopman, Rutger-Jan Swijnenburg, Geraldine R. Vink, Karen Bolhuis, and Geert Kazemier. Their collaborative work is often published in widely recognized venues, with the most frequent publication outlets being:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • HPB
  • European Journal of Cancer

Best Publications

  • Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

    Joel Shapiro;J Jan B van Lanschot;Maarten C C M Hulshof;Pieter van Hagen

  • Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.

    Thierry André;Kai-Keen Shiu;Tae Won Kim;Benny Vittrup Jensen

  • Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

    David Cunningham;Seppo Pyrhönen;Roger D James;Cornelis J A Punt

  • Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

    Marc Peeters;Timothy Jay Price;Andrés Cervantes;Alberto F. Sobrero

  • Direct detection of early-stage cancers using circulating tumor DNA

    Jillian Phallen;Mark Sausen;Vilmos Adleff;Alessandro Leal

  • Genome-wide cell-free DNA fragmentation in patients with cancer

    Stephen Cristiano;Alessandro Leal;Jillian Phallen;Jacob Fiksel

  • Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

    I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk

  • Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

    Antoni Ribas;Richard Kefford;Margaret A. Marshall;Cornelis J.A. Punt

  • Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

    Miriam Koopman;Ninja F. Antonini;Joep Douma;Jaap Wals

  • Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

    Eva Versteijne;Mustafa Suker;Karin Groothuis;Janine M Akkermans-Vogelaar

  • A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

    Giuseppe Giaccone;Cornelis J. A. Punt;Yoshitaka Ando;Rita Ruijter

  • Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

    Sabine Venderbosch;Iris D Nagtegaal;Timothy S Maughan;Christopher G Smith

  • Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

    Jan Franko;Qian Shi;Jeffrey P Meyers;Timothy S Maughan

  • Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

    I. Jolanda M. de Vries;Daniëlle J. E. B. Krooshoop;Nicole M. Scharenborg;W. Joost Lesterhuis

  • BRAF mutation in metastatic colorectal cancer.

    Jolien Tol;Iris D Nagtegaal;Cornelis J A Punt

  • Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    Theo Ruers;Frits Van Coevorden;Cornelis J. A. Punt;Jean-Pierre E. N. Pierie

  • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.

    S.J. Cohen;C.J.A. Punt;N. Iannotti;B.H. Saidman

  • From tumour heterogeneity to advances in precision treatment of colorectal cancer

    Cornelis J. A. Punt;Miriam Koopman;Louis Vermeulen

  • Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

    Lieke H. J. Simkens;Harm van Tinteren;Anne May;Albert J. ten Tije

  • Cancer immunotherapy – revisited

    Willem Lesterhuis;J.B.A.G. Haanen;C.J.A. Punt

Frequent Co-Authors

Carl G. Figdor
Carl G. Figdor Radboud University
I. Jolanda M. de Vries
I. Jolanda M. de Vries Radboud University
Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Gosse J. Adema
Gosse J. Adema Radboud University
Gerty Schreibelt
Gerty Schreibelt Radboud University
Arend Heerschap
Arend Heerschap Radboud University
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Pieter J. Tanis
Pieter J. Tanis University of Amsterdam
Alfredo Falcone
Alfredo Falcone University of Pisa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring options in healthcare beyond traditional medical school, online degrees provide flexible, accelerated ways to launch or advance a career. Whether you’re aiming to upskill as a nurse or enter the field quickly, there are a variety of programs available.

Many registered nurses consider rn to bsn programs to enhance their credentials and open doors to higher positions. For those interested in leadership or advanced practice roles, finding the shortest dnp program online can minimize time away from work while advancing expertise in clinical or administrative areas.

If you need flexibility, you might consider online dnp programs without clinicals, which can make it easier to balance studies with job or family responsibilities. For those wishing to start their healthcare careers sooner, a 9 month lpn program offers a fast-track route into practical nursing.

These diverse online pathways make healthcare education more accessible, supporting professionals at every stage of their journey.

Best Scientists Citing Cornelis J. A. Punt

Trending Scientists

Recently Published Articles